|
|
| | Indolizine, 2-(4-methylphenyl)-1-(phenylseleno)- Basic information |
| | Indolizine, 2-(4-methylphenyl)-1-(phenylseleno)- Chemical Properties |
| | Indolizine, 2-(4-methylphenyl)-1-(phenylseleno)- Usage And Synthesis |
| Uses | MeSeI exhibits a weak inhibitory activity against monoamine oxidase MAO-A and MAO-B (IC50=198.8 μM). MeSeI regulates dopamine receptor D2 and norepinephrine receptor α2, β1, and exhibits antidepressant-like effect in mice. MeSeI is orally active[1]. | | References | [1] da Rocha MJ, et al., 1-(Phenylselanyl)-2-(p-tolyl)indolizine: A selenoindolizine with potential antidepressant-like activity in mice mediated by the modulation of dopaminergic and noradrenergic systems. Brain Res. 2024 Jul 1;1834:148904. DOI:10.1016/j.brainres.2024.148904 |
| | Indolizine, 2-(4-methylphenyl)-1-(phenylseleno)- Preparation Products And Raw materials |
|